Building Blocks

<p>1-(4-Chlorobenzyl)-1,4-diazepane is a psychoactive drug that belongs to the group of benzodiazepines. It has been detected in a number of samples taken from people who have consumed psychoactive substances. 1-(4-Chlorobenzyl)-1,4-diazepane is used as an analytical tool for the detection of other drugs, such as amphetamine and pentedrone. It can be analysed using gas chromatography with mass spectrometry (GC/MS) or liquid chromatography with tandem mass spectrometry (LC/MS).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-(4-Chlorophenyl)-3-methyl-1H-pyrazol-5-amine is a sulfate ester that can be found in chondroitin sulfates. Its function is to assemble into a long polymer by reacting with the hydroxyl groups of the polysaccharides. Sulfate esters are also used as drugs, such as in the treatment of rheumatoid arthritis. 1-(4-Chlorophenyl)-3-methyl-1H-pyrazol-5-amine can also inhibit the growth of bacteria and fungi by inhibiting their ability to produce chondroitin sulfate.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5-Amino-6-methoxy-3,4-dihydropyrimidine-4-thione is an organic solvent that belongs to the heterocycles group. It is a pyrimidine derivative of acrylonitrile with a carbanion. The reaction products are dicarbonyl compounds and hydroxylamine. 5-Amino-6-methoxy-3,4-dihydropyrimidine-4-thione reacts with chloride in the presence of sulfur to form tetracyclic products. This compound has been used for researches and as a reagent for the formation of other organic compounds.</p>

<p>Rhodium-catalyzed asymmetric hydrogenation of 1-(3-isopropylphenyl)ethanone with human serum albumin as a chiral ligand produces the corresponding enantiomers in high yield and excellent optical purity. The catalyst is immobilized on an inert support, which allows for easy scale-up and cost-effective production. This process is homogeneous and does not require the use of solvents or reagents that are toxic to humans.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-(Pyridin-3-yl)propanoic acid is a quinoline derivative that has been shown to be safe and effective in clinical trials. It is being tested for the treatment of type 2 diabetes, obesity, and metabolic syndrome. The oral administration of this drug inhibits the activity of dipeptidyl peptidase-4 (DPP-4), which is an enzyme involved in the degradation of insulin. This inhibition leads to increased levels of insulin in the blood and improved glucose tolerance. 2-(Pyridin-3-yl)propanoic acid interacts with other drugs through competitive inhibition at their binding sites on enzymes. Optimization experiments have shown that it can interact with pyridine compounds, which are found in many drugs including acetaminophen and caffeine.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Carbamoylamino)-3-(thiophen-2-yl)propanoic acid is an organic compound that is used as a building block in the synthesis of complex carbohydrates. It has been shown to be a substrate for the modification of oligosaccharides and glycosylations, where it can be modified with methylation, fluorination, or click chemistry. 3-(Carbamoylamino)-3-(thiophen-2-yl)propanoic acid is also used in the synthesis of polysaccharides such as saccharide and glycoproteins. This product has high purity and is available at custom synthesis scales.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Ethyl-3-hydroxy-1,2-dihydropyridin-2-one (EHDP) is a potential therapeutic agent for the treatment of Alzheimer's disease. It has been shown to inhibit the formation of amyloid beta peptides that are thought to cause Alzheimer's disease. EHDP may be effective in preventing or slowing the progression of Alzheimer's disease by blocking the production of amyloid beta peptides and by preserving long term potentiation in neurons. This compound is also capable of crossing the blood brain barrier and has been shown to bind to citric acid at high affinity.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>3-(Hydroxymethyl)-2(1H)-quinolinone is a potent GABA antagonist with a low micromolar range of activity. It is used as a tool to evaluate the profile of GABA receptors and their kinetics, as well as to study the antagonistic activity at these receptors. 3-(Hydroxymethyl)-2(1H)-quinolinone has been shown to have antagonistic properties against glutamate and glycine receptors, although it does not bind to benzodiazepine or barbiturate binding sites. This drug has proapoptotic properties, which relates to its ability to induce neuronal cell death by apoptosis. 3-(Hydroxymethyl)-2(1H)-quinolinone also photolyzes in the presence of light and can be used for photodynamic therapy, which is an effective treatment for brain cancer.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-(Carboxymethyl)phenylboronic acid is a corrosion inhibitor that is used in the production of polyvinyl chloride, polyvinyl alcohol, and ethylene glycol. It can be used as an additive to lubricating oils and fuels. 4-(Carboxymethyl)phenylboronic acid has been shown to inhibit the corrosion of lead in hydrochloric acid solutions. This compound has also been shown to inhibit the formation of silicon-sulfide complexes in polystyrene and polyvinyl chloride.</p>

<p>Versatile small molecule scaffold</p>

<p>3-(2-Chloroethyl)imidazolidine-2,4-dione (3CI) belongs to the class of intramolecular corroborating advances. It is a chemical compound that can be used in kinetic analyses of pathways and mechanisms. 3CI has been shown to lower the activation energy for reactions and quantification of benzyl yields. The mechanism of action is through the lowering of activation energies and by quantifying yields.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Methoxy-pyridine-2-carboxylic acid amide is a multinuclear compound that can be classified as a pyridine molecule. It has anions that are capable of hydrogen bonding, which is important for its interaction with other molecules. The compound also mimics the properties of benzene and cyclic compounds. 4-Methoxy-pyridine-2-carboxylic acid amide has been shown to have magnetic properties and catalytic activity in the presence of counterion, such as hydrogen ions or sodium hydroxide.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methylcyclohexane-1-carbonitrile is a phenoxide that is formed by the reaction of silicon and carbon. It has an empirical formula of C6H4O2NSi and a molecular weight of 122.14 g/mol. 2-Methylcyclohexane-1-carbonitrile has been found to yield a variety of products, including carbons, phenol, and cyclohexanol.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-5-ethylpyridine is a chemical compound that belongs to the class of heterocyclic compounds. It is used as a catalyst in catalytic reduction and metabolic rate studies. This compound has been found to increase the production of flavopereirine, an important intermediate in the metabolism of plant polyphenols. 2-Chloro-5-ethylpyridine has also been shown to have an agonistic effect on the long term treatment of diabetes mellitus type 2. This agent has been shown to optimize yields and reduce hypoglycemic effects in animal models.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>